CURN Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Kinarus Therapeutics Holding AG

Watchlist Manager

Watchlist

Price: 17.75 CHF -4.83% Market Closed

Market Cap: CHf94.1m

	Kinarus Therapeutics Holding AG SIX:CURN	CH
A	AT & S Austria Technologie & Systemtechnik AG VSE:ATS	AT
A	Autocorp Holding PCL SET:ACG	TH
T	Techno-Agricultural Supplying JSC VN:TSC	VN
N	NSK Ltd XMUN:NSK	JP
B	Basel Medical Group Ltd NASDAQ:BMGL	SG
	Sanki Engineering Co Ltd TSE:1961	JP
	Oryzon Genomics SA MAD:ORY	ES
G	GN Store Nord A/S XMUN:GNN	DK
H	Holland Colours NV F:HCY	NL
O	OCI NV OTC:OCINF	NL

Profitability Summary

Kinarus Therapeutics Holding AG's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Healthy Gross Margin

24%

Sustainable 3Y Average Gross Margin

24%

Negative Operating Margin

-5%

Negative 3Y Average Operating Margin

-168%

Negative Net Margin

-5%

Negative 3Y Average Net Margin

-178%

Negative Free Cash Flow Margin

-20%

Strong 3Y Average Free Cash Flow Margin

10%

Negative ROE

-1%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-48%

ROIC is Increasing

-8% > -1%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.